Skip to main
PHAT
PHAT logo

Phathom Pharmaceuticals (PHAT) Market Capitalization Overview

Market Cap: $742.83M as of Jun 13, 2025

$742.83M
Past Month+$499.87M (205.75%)
As of Jun 13, 2025, Phathom Pharmaceuticals (PHAT) has a market capitalization of $742.83M. Over the past 30 days, its market cap has increased by 38.42%, while in the last 12 months, it has increased by 33.79%.

Market capitalization represents the total value of Phathom Pharmaceuticals as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Phathom Pharmaceuticals (PHAT) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Phathom Pharmaceuticals (PHAT) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Phathom Pharmaceuticals (PHAT) Market Cap History

DateMarket CapChange
Jun 2, 2025$323.94M+38.42%
May 1, 2025$234.02M-34.36%
Apr 1, 2025$356.55M+0.08%
Mar 3, 2025$356.25M-7.46%
Feb 3, 2025$384.97M-23.19%
Jan 2, 2025$501.21M-15.84%

Phathom Pharmaceuticals (PHAT) End of Year Market Cap History

DateMarket CapChange
2025$742.83M+33.79%
2024$555.23M+6.22%
2023$522.72M+11.93%
2022$466.99M-24.43%
2021$617.93M-40.41%
2020$1.04B

FAQs About Phathom Pharmaceuticals (PHAT) Market Cap

As of Jun 13, 2025, the market capitalization of Phathom Pharmaceuticals (PHAT) is $742.83M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Phathom Pharmaceuticals’s market capitalization has increased by 205.75%, changing from $242.96M to $742.83M as of Jun 13, 2025.

In the last 3 months, Phathom Pharmaceuticals’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Phathom Pharmaceuticals’s market capitalization increased from $522.72M in January to $555.23M in December, reflecting a 6.22% change.

In the past five years, Phathom Pharmaceuticals (PHAT) has had a compound annual growth rate (CAGR) of -11.74% in market capitalization. This means its market cap has shrunk at an average rate of -11.74% per year.

Phathom Pharmaceuticals (PHAT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.